Trevi Therapeutics, Inc. — SC 13D/A Filings
5 SC 13D/A filings on record
This page lists all SC 13D/A filings submitted to the SEC by Trevi Therapeutics, Inc. (TRVI), sorted by most recent first. Each row links to the full filing on EdgarLookup. Trevi Therapeutics, Inc. has filed 5 SC 13D/A documents with the SEC since 2012. To view all SEC filings by Trevi Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
144/A
3
4
4/A
424B3
424B4
424B5
5
8-A12B
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
PRE 14A
RW
S-1
S-1/A
S-3
S-3/A
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13D/A | NEW ENTERPRISE ASSOCIATES 16, L.P. / TREVI THERAPEUTICS, INC. -- SCHEDULE 13D/A( | 0001072613-24-000813 | Nov 8, 2024 | — |
| SC 13D/A | NEW ENTERPRISE ASSOCIATES 16, L.P. / TREVI THERAPEUTICS, INC. -- SCHEDULE 13D/A( | 0001072613-24-000518 | May 21, 2024 | — |
| SC 13D/A | NEW ENTERPRISE ASSOCIATES 16, L.P. / TREVI THERAPEUTICS -- SCHEDULE 13D/A3 | 0001072613-22-000390 | Apr 25, 2022 | — |
| SC 13D/A | NEW ENTERPRISE ASSOCIATES 16, L.P. / TREVI THERAPEUTICS -- SCHEDULE 13D/A2 | 0001072613-21-000615 | Nov 2, 2021 | — |
| SC 13D/A | NEW ENTERPRISE ASSOCIATES 16, L.P. -- SCHEDULE 13DA1 | 0001072613-20-000163 | Apr 16, 2020 | — |